Trajectories in estimated glomerular filtration rate in youth-onset type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study.


Journal

Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583

Informations de publication

Date de publication:
02 2021
Historique:
received: 20 08 2020
revised: 14 10 2020
accepted: 14 10 2020
pubmed: 11 11 2020
medline: 13 1 2022
entrez: 10 11 2020
Statut: ppublish

Résumé

We sought to characterize the direction and associated factors of eGFR change following diagnosis of youth-onset type 1 and type 2 diabetes. We assessed the direction of eGFR change at two visits (mean 6.6 years apart) in SEARCH, a longitudinal cohort study of youth-onset type 1 and type 2 diabetes. We used the CKiD Estimated GFR declined in 23.8% and rose in 2.8% of participants with type 1 diabetes (N = 1225; baseline age 11.4 years), and declined in 18.1% and rose in 15.6% of participants with type 2 diabetes (N = 160; baseline age 15.0 years). Factors associated with rising and declining eGFR (versus stable) in both type 1 and type 2 diabetes included sex, age at diagnosis, baseline eGFR and difference in fasting glucose between study visits. Additional factors in type 1 diabetes included time from baseline visit, HbA1c and body mass index. Over the first decade of diabetes, eGFR decline is more common in type 1 diabetes whereas eGFR rise is more common in type 2 diabetes.

Identifiants

pubmed: 33168393
pii: S1056-8727(20)30549-3
doi: 10.1016/j.jdiacomp.2020.107768
pmc: PMC7855388
mid: NIHMS1645080
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107768

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK057516
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000247
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002710
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000154
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002714
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000248
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000244
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000062
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002709
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000077
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000250
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002708
Pays : United States
Organisme : HSRD VA
ID : HIR 10-001
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK127208
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000423
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000246
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000254
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Lancet Diabetes Endocrinol. 2015 May;3(5):382-91
pubmed: 25943757
Diabetes Care. 2012 Jun;35(6):1265-71
pubmed: 22432116
Clin Chem. 2011 Dec;57(12):1693-702
pubmed: 21980171
J Clin Endocrinol Metab. 2010 Jul;95(7):3360-7
pubmed: 20444913
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):254-61
pubmed: 26792530
Pediatr Nephrol. 2010 May;25(5):927-34
pubmed: 20012996
J Am Soc Nephrol. 1999 Aug;10(8):1778-85
pubmed: 10446946
JAMA. 2017 Feb 28;317(8):825-835
pubmed: 28245334
J Diabetes Complications. 2016 Mar;30(2):256-61
pubmed: 26794645
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356
Diabetes Res Clin Pract. 2017 Aug;130:258-265
pubmed: 28666182
Pediatr Nephrol. 2006 Sep;21(9):1299-306
pubmed: 16794818
Diabetes Care. 2013 Dec;36(12):3863-9
pubmed: 23846814
Clin J Am Soc Nephrol. 2009 Nov;4(11):1832-43
pubmed: 19820136
Curr Opin Nephrol Hypertens. 2015 Jan;24(1):96-103
pubmed: 25470017
Diabetes Care. 2007 Oct;30(10):2593-8
pubmed: 17630264
Diabetes Care. 2011 Jul;34(7):1628-33
pubmed: 21636800
Am J Kidney Dis. 2014 May;63(5):820-34
pubmed: 24485147
J Am Soc Nephrol. 2009 Aug;20(8):1813-21
pubmed: 19443635
Diabetes Care. 2013 Jun;36(6):1735-41
pubmed: 23704672
J Diabetes Complications. 2018 Dec;32(12):1160-1168
pubmed: 30316542
J Diabetes Complications. 2014 Jan-Feb;28(1):10-6
pubmed: 24211091
Diabetes Care. 2014 Dec;37(12):3336-44
pubmed: 25414389
Kidney Int. 2010 Mar;77(5):375-7
pubmed: 20150934
Curr Opin Nephrol Hypertens. 2011 May;20(3):246-57
pubmed: 21422923
J Diabetes Complications. 2013 Mar-Apr;27(2):123-7
pubmed: 23182925
N Engl J Med. 2017 Apr 13;376(15):1419-1429
pubmed: 28402773
Clin Chem. 2011 May;57(5):777-8
pubmed: 21364028
Diabetes Care. 2012 Oct;35(10):2061-8
pubmed: 22773704
Adv Data. 2000 Jun 8;(314):1-27
pubmed: 11183293
N Engl J Med. 2019 Jun 13;380(24):2295-2306
pubmed: 30990260
Sci Rep. 2017 Apr 03;7:45522
pubmed: 28368024
J Am Soc Nephrol. 2006 Jun;17(6):1703-9
pubmed: 16672313
Diabet Med. 2010 Dec;27(12):1358-65
pubmed: 21059087
Scand J Clin Lab Invest. 1991 Dec;51(8):715-27
pubmed: 1666932
Nephrol Dial Transplant. 2015 Jun;30(6):918-23
pubmed: 25183630
Diabetologia. 2011 Jan;54(1):78-86
pubmed: 20886205
JAMA. 2016 Aug 9;316(6):602-10
pubmed: 27532915
Am J Kidney Dis. 2018 Oct;72(4):538-546
pubmed: 30031564
BMC Nephrol. 2016 Nov 10;17(1):172
pubmed: 27832768
Nephrol Dial Transplant. 2015 Oct;30(10):1706-11
pubmed: 26050268
Nucl Med Commun. 2005 Jan;26(1):61-5
pubmed: 15604949
J Am Soc Nephrol. 2014 Apr;25(4):810-8
pubmed: 24309189
Vital Health Stat 2. 2003 Sep;(135):1-55
pubmed: 14556588
Stat Med. 2007 Jan 30;26(2):443-57
pubmed: 16526009
Clin J Am Soc Nephrol. 2011 Jul;6(7):1599-608
pubmed: 21700821
Circulation. 2014 Feb 4;129(5):587-97
pubmed: 24334175

Auteurs

Katherine D Westreich (KD)

University of North Carolina Kidney Center, UNC School of Medicine, Chapel Hill, NC, United States of America. Electronic address: kdwestre@email.unc.edu.

Scott Isom (S)

Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America. Electronic address: sisom@wakehealth.edu.

Jasmin Divers (J)

Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America. Electronic address: jasmin.divers@nyulangone.org.

Ralph D'Agostino (R)

Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America. Electronic address: rdagosti@wakehealth.edu.

Jean M Lawrence (JM)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States of America. Electronic address: Jean.M.Lawrence@kp.org.

Roopa Kanakatti Shankar (R)

Division of Endocrinology, Children's National Medical Center, Washington, DC, United States of America.

Lawrence M Dolan (LM)

Division of Endocrinology, Cincinnati Children's Hospital, Cincinnati, OH, United States of America. Electronic address: Larry.Dolan@cchmc.org.

Giuseppina Imperatore (G)

Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States of America. Electronic address: gai5@cdc.org.

Dana Dabelea (D)

Department of Epidemiology, School of Public Health, University of Colorado Denver, Aurora, CO, United States of America. Electronic address: Dana.Dabelea@cuanschutz.edu.

Elizabeth J Mayer-Davis (EJ)

Department of Nutrition, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, United States of America; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, United States of America. Electronic address: mayerdav@email.unc.edu.

Amy K Mottl (AK)

University of North Carolina Kidney Center, UNC School of Medicine, Chapel Hill, NC, United States of America. Electronic address: amy_mottl@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH